Taglich Brothers Upgrades SurgiCare, Inc. to a Speculative Buy

Houston, Texas, UNITED STATES


NEW YORK, Sept. 21, 2001 (PRIMEZONE) -- Taglich Brothers has upgraded SurgiCare (AMEX:SRG) to a Speculative Buy from a Not Rated, with a fifteen-month price target of $7.50.

SurgiCare has demonstrated that it is well positioned to continue expanding over the next few years while growing both revenues and earnings. The Company's recent partnership agreement with Cirrus Health Services has already given rise to the Company's fourth center, Bayside SurgiCare Ambulatory Surgery Center, in Houston. SurgiCare and Cirrus have also begun construction on the Park Cities SurgiCare Ambulatory Surgery Center in Dallas, scheduled to be completed in the summer of 2002. In addition, the two company's plan to co-develop and manage a specialty hospital focused on specific surgical procedures and associated support services, located in North Houston. SurgiCare owns and operates ambulatory surgery centers in the Houston area.

Taglich Brothers, Inc. is full-service broker dealer focused exclusively on micro-cap companies. The Company defines the micro-cap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers, Inc. currently offers institutional brokerage services, investment banking and comprehensive research coverage to the investment community.

Additional information is available upon request or on our website at http://www.taglichbrothers.com.

The information and statistical data contained herein have been obtained from sources, which we believe to be reliable but in no way are warranted by us as to accuracy or completeness. We do not undertake to advise you as to change in figures or our views. This is not a solicitation of any order to buy or sell. Taglich Brothers, Inc. is not a market maker and does not sell to or buy from customers on a principal basis. We, our affiliates, any officer, director or stockholder or any member of their families may from time to time purchase or sell any of the above-mentioned or related securities. The above statement is the opinion of Taglich Brothers, Inc. and is not a guarantee that the target price for the stock will be met or that predicted business results for the company will occur. As of the date of this report, we, our affiliates, any officer, director or stockholder, or any member of their families do not have a position in the stock of the company mentioned in this report. Taglich Brothers, Inc., does not currently have an Investment Banking relationship with the company and was not a manager or co-manager of any offering for the company within the last three years. The company does pay Taglich Brothers Inc. a monthly fee for maintenance of our Web site.

Taglich Brothers, Inc. The Standard of Excellence in the Micro-Cap Market Member: NASD, SIPC



        

Contact Data